Polyacrylic acid/polyvinylpyrrolidone bipolymeric systems. I. Rheological and mucoadhesive properties of formulations potentially useful for the treatment of dry-eye-syndrome

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 47, Issue 2, 1999, Pages 113-118

  Oechsner, Matthias ^a   Keipert, Sigrid ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

Author keywords

Dry eye syndrome; Mucoadhesion; Ocular; Polyacrylic acid; Polyvinylpyrrolidone; Rheology

Indexed keywords

POLYACRYLIC ACID; POLYMER; POVIDONE; THILO TEARS; UNCLASSIFIED DRUG; VIDISIC;

ARTICLE; DRUG FORMULATION; DRY EYE; FLOW KINETICS; FLUORESCENCE POLARIZATION; VISCOSITY;

ACRYLIC RESINS; ADHESIVENESS; DRY EYE SYNDROMES; FLUORESCENCE POLARIZATION; HUMANS; MUCINS; POVIDONE; VISCOSITY;

EID: 0033007999     PISSN: 09396411     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0939-6411(98)00070-8     Document Type: Article

References (20)

1. G. Ponchel, F. Touchard, D. Duchêne, N.A. Peppas, Bioadhesive analysis of controlled-release systems. I. Fracture and interpenetration analysis in poly (acrylic acid)-containing systems, J. Contr. Rel. 5 (1987) 129-141.
2. D. Duchêne, F. Touchard, N.A. Peppas, Pharmaceutical and medical aspects of bioadhesive systems for drug administration, Drug Dev. Ind. Pharm. 14 (1988) 283-318.
3. A.J. Winfield, D. Jessiman, A. Williams, L. Esakowitz, A study of the causes of non-compliance by patients prescribed eyedrops, Br. J. Ophthalmol. 74 (1990) 477-480.
4. J. Ehlert, Tropfbare Ophthalmika mit retardierender Wirkung. Diplomarbeit, Berlin, 1988.
5. I. Soutar, L. Swanson, R.E. Imhof, G. Rumbles, Synchroton-generated time-resolved fluorescence anisotropy studies of the segmental relaxation of poly (acrylic acid) and poly (methacrylic acid) in dilute methanolic solutions, Macromolecules 25 (1992) 4399-4405.
6. E.E. Hassan, J.M. Gallo, Simple rheological method for the in vitro assessment of mucin-polymer bioadhesive bond strength, Pharm. Res. 7 (1990) 491-495.
7. N. Ünlü, A. Ludwig, M. van Ooteghem, A.A. Hincal, Formulations of Carbopol 940 ophthalmic vehicles, and in vitro evaluation of the influence of simulated lacrimal fluid on their physico-chemical properties, Pharmazie 46 (1991) 784-788.
8. J.J. Heyward, K.P. Ghiggino, Fluorescence polarization study of the poly (acrylic acid)/poly (ethylene oxide) interpolymer complex in aqueous solution, Macromolecules 22 (1989) 1159-1165.
9. N.A. Elgindy, M.A. Elegakey, Carbopol-polyvinylpyrrolidone flocculation, Sci. Pharm. 49 (1981) 427-434.
10. M.E. de Vries, H.E. Boddé, Hydrogels for buccal drug delivery: properties relevant for muco-adhesion, J. Biomed. Mat. Res. 22 (1988) 1023-1032.
11. J.W. Lamble, D. Gilbert, J.J. Ashford, The break-up time of artificial pre-ocular films on the rabbit cornea, J. Pharm. Pharmacol. 28 (1976) 450-451.
12. C.A. Adler, D.M. Maurice, M.E. Paterson, The effect of viscosity of the vehicle on the penetration of fluorescein into the human eye, Exp. Eye Res. 11 (1971) 34-42.
13. T.F. Patton, J.R. Robinson, Ocular evaluation of polyvinyl alcohol vehicle in rabbits, J. Pharm. Sci. 64 (1975) 1312-1316.
14. S. Mishima, Some physiological aspects of the precorneal tear film, Arch. Ophthalmol. 58 (1965) 434-439.
15. O. Dudinski, B.C. Finnin, B.L. Reed, Acceptability of thickened eye drops to human subjects, Curr. Ther. Res. 33 (1983) 322-337.
16. H. Ibrahim, P. Buri, R. Gurny, Composition, structure et paramètres physiologiques du système lacrymal imliqués dans la conseption des formes ophthalmiques, Pharm. Acta Helv. 63 (1988) 146-154.
17. M. Oechsner, S. Keipert, Tränenersatzpräparate - Indikation, Zusammensetzung und Eigenschaften, PZ Prisma 2 (1997) 76-83.
18. M. Oechsner, Bipolymere Zubereitungen auf Polyacrylsäure-Basis zur Anwendung in der Therapie der Keratoconjunktivitis sicca und des Glaukoms. PhD thesis, Berlin, 1998.
19. J.L. Chen, G.N. Cyr, Composition producing adhesion through hydration, in: R.S Manly (Ed.), Adhesion in Biological Systems, Academic Press, New York, 1970, pp. 163-181.
20. M. Oechsner, S. Keipert, Vergleichende Untersuchungen an kommerziellen und neu entwickelten Tränenersatzpräparaten, 9th Spring Meeting DPhG, Würzburg, 1997.